Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 9, 2008
Novel intestinal splice variants of RNA-binding protein CUGBP2: isoform-specific effects on mitotic catastropheSatish Ramalingam, Gopalan Natarajan, Chris Schafer, et al.
Cells|July 2, 2021
Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon TumorigenesisDharmalingam Subramaniam, Sivapriya Ponnurangam, Satish Ramalingam, et al.
Plos One|February 25, 2011
RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cellsDharmalingam Subramaniam, Satish Ramalingam, David C Linehan, et al.
Gastroenterology|April 9, 2008
Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanismsDharmalingam Subramaniam, Satish Ramalingam, Randal May, et al.
IET Nanobiotechnology|August 15, 2018
Evaluation of potential anti-cancer activity of cationic liposomal nanoformulated <i>Lycopodium clavatum</i> in colon cancer cellsPragyan Paramita, Vimala Devi Subramaniam, Ramachandran Murugesan, et al.
Current Radiopharmaceuticals|April 30, 2025
RNA Binding Proteins are Pivotal Regulators of Cancer Radioresistance and Potential Targets for Preventing Tumor RecurrenceVasanth Kanth Thasma LoganathBabu, Srisri Satishkartik, Vanshikaa Karthikeyan, et al.
Alternative Therapies in Health and Medicine|March 18, 2010
Curcumin and turmeric attenuate arsenic-induced angiogenesis in ovoPanayotis Pantazis, Aarthi Varman, Cindy Simpson-Durand, et al.
Oncotarget|May 2, 2019
Co-localization of autophagy-related protein p62 with cancer stem cell marker dclk1 may hamper dclk1's elimination during colon cancer development and progressionBadal Chandra Roy, Ishfaq Ahmed, Satish Ramalingam, et al.
Gastroenterology|May 13, 2008
Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivoSripathi M Sureban, Randal May, Robert J George, et al.
Stem Cell Investigation|December 9, 2020
Tamoxifen induces stem-like phenotypes and multidrug resistance by altering epigenetic regulators in ERα+ breast cancer cellsAparna Kalyanaraman, Dhanavathy Gnanasampanthapandian, Prasad Shanmughan, et al.
Pageof 6